TGF-β/Smad signaling in the injured liver

被引：155

作者：

Breitkopf, K ^{[1
]}

Godoy, P ^{[1
]}

Ciuclan, L ^{[1
]}

Singer, MV ^{[1
]}

Dooley, S ^{[1
]}

机构：

[1] Heidelberg Univ, Klinikum Mannheim, Dept Med 2, Div Mol Alcohol Res Gastroenterol, Mannheim, Germany

来源：

ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2006年 / 44卷 / 01期

关键词：

TGF-beta; smad; liver; fibrosis; HSC; EMT; interferon-gamma;

D O I：

10.1055/s-2005-858989

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

TGF-beta, acting both directly and indirectly, represents a central mediator of fibrogenic remodeling processes in the liver. Besides hepatic stellate cells (HSCs), which are induced by TGF-beta to transdifferentiate to myofibroblasts and to produce extracellular matrix, hepatocytes are also strongly responsive for this cytokine, which induces apoptosis during fibrogenesis and provides growth control in regeneration processes. Based on this, TGF-beta-mediated hepatic responses to injury are the result of a complex interplay between the different liver cell types. In this review we summarize the knowledge about TGF-beta signal transduction in HSCs with special impact on Smad pathways. We further describe a molecular cross-talk between profibrogenic TGF-beta and antifibrogenic IFN-gamma signaling in liver cells. Finally, we introduce hepatocyte plasticity and epithelial-to-mesenchymal transition in the liver, which is well established in tumorigenesis, as a potential feature of fibrogenesis and highlight possible action points of TGF-beta in these contexts.

引用

收藏

页码：57 / 66

页数：10

相关论文

共 75 条

[51] Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat [J].

Qi, Z ;

Atsuchi, N ;

Ooshima, A ;

Takeshita, A ;

Ueno, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2345-2349

[52] Role of transforming growth factor β type II receptor in hepatic fibrosis:: Studies of human chronic hepatitis C and experimental fibrosis in rats [J].

Roulot, D ;

Sevcsik, AM ;

Coste, T ;

Strosberg, AD ;

Marullo, S .

HEPATOLOGY, 1999, 29 (06) :1730-1738

[53] HEPATIC EXPRESSION OF MATURE TRANSFORMING GROWTH-FACTOR-BETA-1 IN TRANSGENIC MICE RESULTS IN MULTIPLE TISSUE LESIONS [J].

SANDERSON, N ;

FACTOR, V ;

NAGY, P ;

KOPP, J ;

KONDAIAH, P ;

WAKEFIELD, L ;

ROBERTS, AB ;

SPORN, MB ;

THORGEIRSSON, SS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2572-2576

[54]

Sanford LP, 1997, DEVELOPMENT, V124, P2659

[55] The role of Smad3 in mediating mouse hepatic stellate cell activation [J].

Schnabl, B ;

Kweon, YO ;

Frederick, JP ;

Wang, XF ;

Rippe, RA ;

Brenner, DA .

HEPATOLOGY, 2001, 34 (01) :89-100

[56] Mechanisms of TGF-β signaling from cell membrane to the nucleus [J].

Shi, YG ;

Massagué, J .

CELL, 2003, 113 (06) :685-700

[57] TARGETED DISRUPTION OF THE MOUSE TRANSFORMING GROWTH FACTOR-BETA-1 GENE RESULTS IN MULTIFOCAL INFLAMMATORY DISEASE [J].

SHULL, MM ;

ORMSBY, I ;

KIER, AB ;

PAWLOWSKI, S ;

DIEBOLD, RJ ;

YIN, MY ;

ALLEN, R ;

SIDMAN, C ;

PROETZEL, G ;

CALVIN, D ;

ANNUNZIATA, N ;

DOETSCHMAN, T .

NATURE, 1992, 359 (6397) :693-699

[58] Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view [J].

Sobesky, R ;

Mathurin, P ;

Charlotte, F ;

Moussalli, J ;

Olivi, M ;

Vidaud, M ;

Ratziu, V ;

Opolon, P ;

Poynard, T .

GASTROENTEROLOGY, 1999, 116 (02) :378-386

[59] SOME RECENT ADVANCES IN THE CHEMISTRY AND BIOLOGY OF TRANSFORMING GROWTH-FACTOR-BETA [J].

SPORN, MB ;

ROBERTS, AB ;

WAKEFIELD, LM ;

DECROMBRUGGHE, B .

JOURNAL OF CELL BIOLOGY, 1987, 105 (03) :1039-1045

[60] Genomic locus and promoter region of rat Smad7, an important antagonist of TGFβ signaling [J].

Stopa, M ;

Benes, V ;

Ansorge, W ;

Gressner, AM ;

Dooley, S .

MAMMALIAN GENOME, 2000, 11 (02) :169-176

← 1 2 3 4 5 6 7 8 →